Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cardiovascular Research

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0008-6363(00)00029-8PMID 10773235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

  1999cited by this paper
• Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.

  1999cited by this paper
• Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1.

  1999cited by this paper
• Extracellular matrix gene expression in the left ventricular tissue of spontaneously hypertensive rats.

  1999cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells.

  1999cited by this paper
• Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function.

  1999cited by this paper
• Defects in Matrix Metalloproteinase Inhibitory Stoichiometry and Selective MMP Induction in Patients with Nonischemic or Ischemic Dilated Cardiomyopathy

  1999cited by this paper
• Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction.

  1999cited by this paper
• Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.

  1999cited by this paper
• Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.

  1999cited by this paper
• Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.

  1998cited by this paper
• Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.

  1998cited by this paper
• Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.

  1998cited by this paper
• Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.

  1998cited by this paper
• Doppler echocardiographic assessment and cardiac gene expression analysis of the left ventricle in myocardial infarcted rats.

  1998cited by this paper
• Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface*

  1998cited by this paper
• Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated Cardiomyopathy

  1998cited by this paper
• Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability.

  1996cited by this paper
• Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models.

  1996cited by this paper
• Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4*

  1996cited by this paper
• A structural disaster: an undermining of underpinnings

  1996cited by this paper
• Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links.

  1996cited by this paper
• The role of matrix metalloproteinases in heart disease.

  1996cited by this paper
• Matrix metalloproteinases and cardiovascular disease.

  1995cited by this paper
• Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.

  1994cited by this paper
• Cardiac myocyte necrosis induced by angiotensin II.

  1991cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.

  1990cited by this paper
• Collagen degradation in ischaemic rat hearts.

  1990cited by this paper

• Qualitative analysis of chemical components in Berberis kaschgarica Rupr. and study on the in vitro anti-inflammatory effects of its alkaloids.

  2026cites this paper
• MMP-responsive hydrogel: a new approach for tissue repair and regeneration

  2026cites this paper
• MK2 deficiency decreases mortality in male mice during the inflammatory phase after myocardial infarction

  2025cites this paper
• Exploring the Impact of NRF2 Signaling on Atherosclerosis: Insights Into Hydrogen Sulfide, NLRP3 Inflammasome, microRNAs, and HO‐1

  2025cites this paper
• Sensitivity Analysis to Isolate the Effects of Proteases and Protease Inhibitors on Extracellular Matrix Turnover

  2025cites this paper
• MiR-150-5p attenuates heart failure by targeting MMP14 to regulate vascular smooth muscle cell function

  2025cites this paper
• Furosemide Promotes Inflammatory Activation and Myocardial Fibrosis in Swine with Tachycardia-Induced Heart Failure

  2025cites this paper
• Empagliflozin attenuates hypoxia-induced heart failure of zebrafish embryos via influencing MMP13 expression.

  2024cites this paper
• Adaptive enzyme-responsive self-assembling multivalent apelin ligands for targeted myocardial infarction therapy.

  2024cites this paper
• Harnessing synergistic effects of MMP-2 Inhibition and bFGF to simultaneously preserve and vascularize cardiac extracellular matrix after myocardial infarction

  2024cites this paper
• The TIMP Protein Family: Diverse Roles in Pathophysiology.

  2024cites this paper
• Redox homeostasis in cardiac fibrosis: Focus on metal ion metabolism

  2024cites this paper
• Fibrinogen Inhibits Metalloproteinase-9 Activation and Syndecan-1 Cleavage to Protect Lung Function in ApoE Null Mice After Hemorrhagic Shock.

  2023cites this paper
• Novel, Blended Polymeric Microspheres for the Controlled Release of Methotrexate: Characterization and In Vivo Antifibrotic Studies

  2023cites this paper
• Bioresponsive Cytokine Delivery Responding to Matrix Metalloproteinases.

  2023cites this paper
• Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice

  2022cites this paper
• Localized Controlled Release of Kynurenic Acid Encapsulated in Synthetic Polymer Reduces Implant—Induced Dermal Fibrosis

  2022cites this paper
• Thymoquinone attenuates isoproterenol‐induced myocardial infarction by inhibiting cytochrome C and matrix metalloproteinase‐9 expression

  2021cites this paper
• Chronic Cadmium Exposure Alters Cardiac Matrix Metalloproteinases in the Heart of Sprague-Dawley Rat

  2021cites this paper
• Molecular, Gene, and Cellular Mechanism

  2021cites this paper
• Hepatocyte growth factor (HGF) and insulin-like growth factor 1 (IGF-1) improved ventricular remodeling after myocardial infarction through inhibiting MMP8/13 in a rat model

  2021cites this paper
• Improvement of wound healing by the development of ECM-inspired biomaterial coatings and controlled protein release

  2021cites this paper
• Effect of TGF-β1 on myocardial cell apoptosis in rats with acute myocardial infarction via MAPK signaling pathway.

  2020cites this paper
• Matrix Metalloproteinases Increase Due to Hypoperfusion in Obstructive Hypertrophic Cardiomyopathy.

  2020cites this paper
• Significance of plasma free fatty acid level for assessing and diagnosing acute myocardial infarction.

  2020cites this paper
• Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post–Myocardial Infarction Remodeling

  2020cites this paper
• TIMP-3 and MI Remodeling JPET-AR-2020-000047 Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-MI Remodeling

  2020cites this paper
• The role of matrix metalloproteinases in the myocardial remodeling

  2020cites this paper
• Myocardial Cell Aging in the Elderly

  2020cites this paper
• GENE EXPRESSION PATTERN ANALYSIS FOR FORENSIC DIAGNOSIS OF SUDDEN CARDIAC DEATH

  2020cites this paper
• Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy

  2020cites this paper
• Cardiorenal syndrome:pathophysiology and potential role of uremic toxins

  2019cites this paper
• Computational Model Predicts Paracrine and Intracellular Drivers of Fibroblast Phenotype After Myocardial Infarction

  2019cites this paper
• Gelatin Based Polymer Cell Coating Improves Bone Marrow-Derived Cell Retention in the Heart after Myocardial Infarction

  2019cites this paper
• Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats.

  2019cites this paper
• Regulation of the anti-inflammatory properties of MSCspheroids by matrix metalloproteinases

  2019cites this paper
• Zinc Deficiency Promoted Fibrosis via ROS and TIMP/MMPs in the Myocardium of Mice

  2019cites this paper
• WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling

  2019cites this paper
• ERK1/2 mediates the lipopolysaccharide-induced upregulation of FGF-2, uPA, MMP-2, MMP-9 and cellular migration in cardiac fibroblasts.

  2019cites this paper
• Protease-Activatable Adeno-Associated Virus Vector for Gene Delivery to Damaged Heart Tissue.

  2019cites this paper
• mRNA expression patterns in human myocardial tissue, pericardial fluid and blood, and its contribution to the diagnosis of cause of death.

  2019cites this paper
• Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy

  2018cites this paper
• Surgical reinforcement alters collagen alignment and turnover in healing myocardial infarcts.

  2018cites this paper
• Research Progress on the Relationship between Atherosclerosis and Inflammation

  2018cites this paper
• Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence

  2018cites this paper
• Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy.

  2017cites this paper
• The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

  2017cites this paper
• Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

  2017cites this paper
• Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.

  2017influential citation
• Attenuation of the LPS‐induced, ERK‐mediated upregulation of fibrosis‐related factors FGF‐2, uPA, MMP‐2, and MMP‐9 by Carthamus tinctorius L in cardiomyoblasts

  2017cites this paper
• Relationship among LRP1 expression, Pyk2 phosphorylation and MMP‐9 activation in left ventricular remodelling after myocardial infarction

  2017cites this paper
• MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.

  2017cites this paper
• Fibrosis‐Related Gene Expression in Single Ventricle Heart Disease

  2017cites this paper
• C-1562T polymorphism of matrix metalloproteinase-9 (MMP-9) gene associated with elevated level of plasma MMP-9 concentration in patient with acute myocardial infarction (AMI) in Denpasar-Bali

  2017cites this paper
• microRNAs-Mediated MMPs Regulation: Novel Mechanism for Cardiovascular Diseases

  2017cites this paper
• Evaluation of zinc binding groups (ZBGs) as inhibitor building blocks using carbonic anhydrase and the catalytic domain of matrix metalloproteinase 12 (cdMMP-12)

  2017cites this paper
• The influence of oral copper-methionine on matrix metalloproteinase-2 gene expression and activation in right-sided heart failure induced by cold temperature: A broiler chicken perspective.

  2017cites this paper
• Subacute Cardiovascular Toxicity of the Marine Phycotoxin Azaspiracid-1 in Rats.

  2016cites this paper
• Metalloproteinases and Their issue Inhibitors in Pressure-Overloaded uman Myocardium During Heart Failure Progression

  2016cites this paper
• Matrix Proteins and Proteinases Network in Human Cardiovascular Diseases Explored By Cytoscape

  2016cites this paper
• Bioactive Lipids and Circulating Progenitor Cells in Patients with Cardiovascular Disease

  2016cites this paper
• Modifying the mechanics of healing infarcts: Is better the enemy of good?

  2016cites this paper
• Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.

  2016cites this paper
• Putative targeting of matrix metalloproteinase-8 in atherosclerosis.

  2015influential citation
• Exercise attenuates inflammation and limits scar thinning after myocardial infarction in mice.

  2015cites this paper
• The p66ShcA adaptor protein regulates healing after myocardial infarction

  2015cites this paper
• Studies on Establishment of Cardiotoxicity Biomarkers in Rats Based on Toxicogenomic Technologies

  2015cites this paper
• Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine

  2015cites this paper
• Controlled delivery of stromal derived factor-1α from poly lactic-co-glycolic acid core-shell particles to recruit mesenchymal stem cells for cardiac regeneration.

  2015cites this paper
• Aação do extrato etanólico da casca do pequi na cardiotoxicidade por doxorrubicina em ratos

  2015influential citation
• Physiological Implications of Myocardial Scar Structure.

  2015cites this paper
• Strategies for recruitment of stem cells to treat myocardial infarction.

  2015cites this paper
• RIPC for multiorgan salvage in clinical settings: evolution of concept, evidences and mechanisms.

  2015cites this paper
• Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling

  2014cites this paper
• Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.

  2014cites this paper
• MMPs in Cardiovascular Diseases: Emerging Pharmacological Targets

  2014cites this paper
• Emerging Role of Genetic Variants of Matrix Metalloproteinases Genes in Left Ventricular Dysfunction

  2014cites this paper
• Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction

  2014cites this paper
• Association of endostatin with mortality in patients with chronic heart failure

  2014cites this paper
• Adenosine A2B receptor effects on post-MI remodeling and cardiac fibroblast function

  2014cites this paper
• Targeting MMP-2 to treat ischemic heart injury

  2014cites this paper
• Role of Protease Activation in Subcellular Remodeling and Heart Failure

  2014cites this paper
• Modifying matrix remodeling to prevent heart failure

  2014cites this paper
• The transcriptomic profile of peripheral blood nuclear cells in dogs with heart failure

  2014cites this paper
• Matrix metalloproteinases in biologic samples.

  2014cites this paper
• Mechanisms Regulating Trafficking of Stem Cells in Ischemic Heart Disease

  2014cites this paper
• Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.

  2014cites this paper
• Adult Stem Cell Therapies: Alternatives to Plasticity

  2014cites this paper
• Aging-Related Changes in Extracellular Matrix: Implications for Ventricular Remodeling Following Myocardial Infarction

  2014influential citation
• 0335: Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1

  2014cites this paper
• Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.

  2014cites this paper
• Baicalein inhibits HMGB1 release and MMP-2/-9 expression in lipopolysaccharide-induced cardiac hypertrophy.

  2014cites this paper
• The use of MMP2 antibody-conjugated cationic microbubble to target the ischemic myocardium, enhance Timp3 gene transfection and improve cardiac function.

  2014cites this paper
• Endoglin: a critical mediator of cardiovascular health

  2013cites this paper
• The Role of the Macrophage in the Development of Aortic Dissection

  2013cites this paper
• Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury.

  2013cites this paper
• Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats

  2013cites this paper
• Identification of Temporal and Region-Specific Myocardial Gene Expression Patterns in Response to Infarction in Swine

  2013cites this paper
• The oxygen free radicals control MMP-9 and transcription factors expression in the spontaneously hypertensive rat.

  2013cites this paper
• Genomic biomarkers for cardiotoxicity in rats as a sensitive tool in preclinical studies

  2013cites this paper